Table 1.

Demographic characteristics of the Parkinson’s disease patients with and without pathological gambling

	Parkinson’s disease patients with pathological gambling (n = 7)	Parkinson’s disease patients without pathological gambling (n = 7)	P-value
Gender	Five males, two females	Six males, one female
Age	47–72 years	51–74 years	0.5
H & Y, mean (±SD)	2 (±0.6)	1.9 (±0.7)	0.6
PDRS (III), mean (±SD), off medication	25.2 (±4.5)	20.2 (±5.4)	0.09
Disease duration, mean years (±SD)	7.4 (±3.2)	5.6 (±2.5)	0.15
Current Total LEDD, mean (±SD)	856 (±407) mg	756 (± 400) mg	0.6
Current Dopamine agonist LEDD, mean (±SD)	138 (±172) mg	167 (±113) mg	0.7
MoCA, mean (±SD)	26 (±3.2)	28 (±2.3)	0.2
G-SAS, mean (±SD)	34.8 (±5.6)	4.6 (±6.3)	<0.001

H & Y = Hoehn and Yahr; UPDRS III = Unified Parkinson’s Disease Rating Scale, motor score; LEDD = levodopa equivalent daily dose: L-dopa dose + L-dopa dose × 1/3 if on entacapone + bromocriptine (mg) × 10 + cabergoline or pramipexole (mg) × 67 + ropinirole (mg) × 20 + pergolide (mg) × 100 + apomorphine (mg) × 8 (from Evans et al., 2004); MocA = Montreal Cognitive Assessment; G-SAS = Gambling Symptom Assessment Scale.